Fintel reports that on October 31, 2025, Needham reiterated coverage of Gilead Sciences (NasdaqGS:GILD) with a Buy recommendation.
Analyst Price Forecast Suggests 8.29% Upside
As of October 30, 2025, the average one-year price target for Gilead Sciences is $129.72/share. The forecasts range from a low of $101.00 to a high of $150.15. The average price target represents an increase of 8.29% from its latest reported closing price of $119.79 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Gilead Sciences is 27,582MM, a decrease of 5.17%. The projected annual non-GAAP EPS is 7.23.
What is the Fund Sentiment?
There are 3,396 funds or institutions reporting positions in Gilead Sciences. This is an increase of 83 owner(s) or 2.51% in the last quarter. Average portfolio weight of all funds dedicated to GILD is 0.45%, an increase of 8.09%. Total shares owned by institutions increased in the last three months by 0.47% to 1,294,184K shares. 
The put/call ratio of GILD is 0.62, indicating a bullish outlook.
What are Other Shareholders Doing?
Capital World Investors holds 46,303K shares representing 3.73% ownership of the company. In its prior filing, the firm reported owning 53,548K shares , representing a decrease of 15.65%. The firm decreased its portfolio allocation in GILD by 23.24% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 40,008K shares representing 3.22% ownership of the company. In its prior filing, the firm reported owning 39,370K shares , representing an increase of 1.59%. The firm decreased its portfolio allocation in GILD by 10.29% over the last quarter.
Wellington Management Group Llp holds 37,531K shares representing 3.02% ownership of the company. In its prior filing, the firm reported owning 27,359K shares , representing an increase of 27.10%. The firm increased its portfolio allocation in GILD by 28.07% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 35,307K shares representing 2.85% ownership of the company. In its prior filing, the firm reported owning 34,629K shares , representing an increase of 1.92%. The firm decreased its portfolio allocation in GILD by 10.37% over the last quarter.
Capital Research Global Investors holds 31,098K shares representing 2.51% ownership of the company. In its prior filing, the firm reported owning 54,610K shares , representing a decrease of 75.61%. The firm decreased its portfolio allocation in GILD by 48.12% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
